Protective effects of N-acetylserotonin against 6-hydroxydopamine-induced neurotoxicity

Life Sci. 2005 Mar 25;76(19):2193-202. doi: 10.1016/j.lfs.2004.09.035.

Abstract

The present work studied in vivo neuroprotective effects of n-acetylserotonin (NAS), the immediate precursor of melatonin, on the dopaminergic system, in rats lesioned with the unilateral intrastriatal injection of the neurotoxin 6-hydroxydopamine (6-OHDA). Two weeks after the lesion, the dopamine receptor agonist, apomorphine, produced rotational asymmetry, and the NAS treatment significantly reduced the motor deficit following the apomorphine challenge. The apomorphine-induced rotational behavior was blocked by 84, 86 and 53% after NAS, at doses of 2, 5 and 10 mg/kg, i.p., respectively. The injection of 6-OHDA significantly decreased DA, DOPAC and HVA levels in the rat striatum. In contrast, the NAS (2, 5 and 10 mg/kg, i.p., daily for 7 days) treatment partially reversed the decreases caused by 6-OHDA, and the neurotransmitter levels were brought to approximately 50% of that observed in the contralateral sides. NAS was more efficient at the smaller doses. NAS (5 mg/kg) produced an up-regulation of D1 (37%) and D2 (37%) receptors associated with a decrease in Kd values.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apomorphine / pharmacology
  • Benzazepines / metabolism
  • Binding, Competitive / drug effects
  • Biogenic Monoamines / metabolism
  • Cell Count
  • Dopamine / metabolism
  • Dopamine Agonists / pharmacology
  • Dopamine Antagonists / metabolism
  • Male
  • Microinjections
  • Neostriatum / drug effects
  • Neostriatum / metabolism
  • Neostriatum / pathology
  • Neurons / drug effects
  • Neurons / pathology
  • Neurotoxicity Syndromes / pathology
  • Neurotoxicity Syndromes / prevention & control*
  • Oxidopamine / administration & dosage
  • Oxidopamine / antagonists & inhibitors*
  • Oxidopamine / toxicity*
  • Rats
  • Rats, Wistar
  • Receptors, Dopamine D1 / drug effects
  • Receptors, Dopamine D2 / drug effects
  • Rotation
  • Serotonin / analogs & derivatives*
  • Serotonin / metabolism
  • Serotonin / pharmacology*
  • Stereotyped Behavior / drug effects
  • Sympatholytics / administration & dosage
  • Sympatholytics / antagonists & inhibitors*
  • Sympatholytics / toxicity*

Substances

  • Benzazepines
  • Biogenic Monoamines
  • Dopamine Agonists
  • Dopamine Antagonists
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • Sympatholytics
  • Serotonin
  • Oxidopamine
  • Apomorphine
  • N-acetylserotonin
  • Dopamine